Orexin-2 Receptor (HCRTR2/HcrtR2/OX2R) neurons express the orexin-2 receptor, one of two orexin receptors (HCRTR1 and HCRTR2). The orexin system is crucial for wakefulness, arousal, and energy homeostasis. HCRTR2-expressing neurons are primarily located in brain regions involved in sleep-wake regulation, motivation, and autonomic function. These neurons are targets for the treatment of sleep disorders and have implications for neurodegenerative diseases.
The HCRTR2 gene (Hypocretin/Orexin Receptor 2) is located on chromosome 6p12 and encodes a G protein-coupled receptor. Key features:
- Gene ID: 3362
- Protein length: 460 amino acids
- Molecular weight: ~52 kDa
- G protein coupling: Gq, Gs - activates PLCβ and stimulates cAMP
OX2R possesses the classic seven-transmembrane GPCR structure:
- N-terminal extracellular domain - orexin-A and orexin-B binding
- Seven transmembrane helices (TM1-TM7)
- Third intracellular loop - G protein coupling
- C-terminal intracellular tail - phosphorylation sites
¶ Ligands
Orexin-2 receptor binds orexin neuropeptides:
- Orexin-A (hypocretin-1) - 33 amino acids, higher affinity for HCRTR2
- Orexin-B (hypocretin-2) - 28 amino acids, equal affinity for HCRTR1/HCRTR2
- Orexin-C - alternative splice product
¶ Anatomy and Distribution
HCRTR2 is expressed in brain regions involved in wakefulness and arousal:
- Tuberomammillary nucleus (TMN) - histaminergic wake-promoting neurons
- Perifornical area (PeF) - orexin neuron population
- Lateral hypothalamus (LH) - orexin/hypocretin neurons
- Arcuate nucleus (ARC) - energy homeostasis
- Prefrontal cortex - executive function
- Piriform cortex - olfactory processing
- Cortical layer 5 - pyramidal neurons
- Locus coeruleus (LC) - noradrenergic wake neurons
- Dorsal raphe nucleus (DRN) - serotonergic neurons
- Pedunculopontine nucleus (PPN) - REM sleep regulation
- Laterodorsal tegmental nucleus (LDT) - cholinergic neurons
- Thalamus - sensory relay
- Amygdala - emotional processing
- Nucleus accumbens - reward processing
- Septal nuclei - limbic functions
HCRTR2 is expressed in:
- Orexin/hypocretin neurons - autocrine signaling
- Wake-promoting neurons - histamine, norepinephrine, serotonin neurons
- GABAergic interneurons - local inhibition
- Astrocytes - metabolic coupling
HCRTR2 neurons exhibit distinctive electrophysiological properties:
- Resting membrane potential: -55 to -70 mV
- Input resistance: 200-500 MΩ
- Firing rate: 5-15 Hz (tonically active)
- Depolarization - orexin activates HCRTR2, increases firing
- Calcium influx - Gq-mediated IP3 production
- Excitability increase - reduced spike threshold
- Synaptic release - enhanced neurotransmitter release
- Tonic firing - sustained activity during wake
- Burst firing - in response to salient stimuli
- Silent periods - during sleep (REM-specific)
- State-dependent activity - highest during active wake
The orexin system is fundamental for arousal:
- Maintenance of wakefulness - orexin tonically activates wake neurons
- Arousal from sleep - orexin burst triggers awakening
- Circadian rhythm - orexin follows circadian pattern
- Energy expenditure - orexin increases during active wake
- REM sleep regulation - orexin neurons inhibit REM
- NREM sleep - orexin activity decreases
- Sleep architecture - orexin stabilizes wake state
- Sleep disorders - narcolepsy involves orexin deficiency
Orexin regulates metabolic functions:
- Food intake - orexin promotes feeding
- Energy expenditure - increases metabolic rate
- Thermoregulation - modulates body temperature
- Weight regulation - orexin dysfunction in obesity
¶ Reward and Motivation
HCRTR2 is involved in reward processing:
- Drug seeking - orexin in addiction
- Motivation - orexin drives goal-directed behavior
- Reward prediction - orexin signals reward value
- Stress-induced relapse - orexin in craving
Orexin modulates autonomic systems:
- Blood pressure - orexin affects cardiovascular function
- Respiration - orexin influences breathing
- Gastrointestinal function - orexin in gut-brain axis
- Hormonal regulation - HPA axis modulation
HCRTR2 activates multiple intracellular cascades:
- Phospholipase C (PLC) activation
- IP3 production - calcium release from endoplasmic reticulum
- DAG formation - PKC activation
- Calcium signaling - neuronal excitation and secretion
- Adenylate cyclase activation (via Gs)
- cAMP production
- PKA activation
- CREB phosphorylation - gene transcription
- ERK1/2 activation
- Cellular growth
- Synaptic plasticity
- Gene expression
HCRTR2 is central to narcolepsy pathophysiology:
- Orexin deficiency - loss of orexin neurons in narcolepsy
- HCRTR2 mutations - rare genetic narcolepsy
- Autoimmune hypothesis - orexin neuron loss
- Therapeutic targeting - HCRTR2 agonists
The orexin system is affected in PD:
- Orexin neuron loss - reduced orexin in PD brains
- Sleep disturbances - REM sleep behavior disorder in PD
- Motor symptoms - orexin in levodopa response
- Cognitive dysfunction - orexin and executive function
- Therapeutic potential - orexin modulation in PD
Orexin alterations in AD:
- Sleep disruption - orexin abnormalities in AD
- Amyloid relationship - orexin affects Aβ
- Memory consolidation - orexin in memory
- Circadian dysfunction - orexin circadian rhythm disruption
- Obesity - orexin in metabolic syndrome
- Depression - orexin in mood disorders
- Anxiety - orexin in stress response
- Epilepsy - orexin in seizure susceptibility
HCRTR2 is a therapeutic target:
- HCRTR2 agonists - narcolepsy treatment
- Dual orexin receptor agonists (DORAs) - suvorexant, lemborexant
- HCRTR2 antagonists - potential for sleep promotion
- Orexin replacement - gene therapy approaches
- Narcolepsy - orexin-based therapies
- Insomnia - orexin modulation
- Parkinson's disease - orexin for sleep/motor symptoms
- Cognitive enhancement - orexin for attention
- HCRTR2 knockout mice - sleep/wake studies
- Orexin/ataxin-3 mice - orexin neuron degeneration model
- iPSC-derived neurons - human orexin system
- Optogenetic manipulation - orexin neuron control
- In situ hybridization - HCRTR2 mRNA distribution
- Immunohistochemistry - receptor localization
- Radioligand binding - receptor density
- Calcium imaging - orexin neuron activity
- EEG/EMG recordings - sleep-wake state analysis
- Behavioral assays - wakefulness testing
- Electrophysiology - patch-clamp recordings
- Metabolic measurements - energy expenditure
-
Sakurai, T. et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92(4), 573-585.
-
de Lecea, L. et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences, 95(1), 322-327.
-
Peyron, C. et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine, 6(9), 991-997.
-
Thannickal, T.C. et al. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27(3), 469-474.
-
Tsujino, N. & Sakurai, T. (2009) Role of orexin in modulating arousal, energy homeostasis and reward. Neuroscience & Biobehavioral Reviews, 33(5), 745-752.
-
Fronczek, R. et al. (2009) Hypocretin/orexin deficiency in human narcolepsy. Sleep Medicine Reviews, 13(1), 9-17.
-
Brisbare-Roch, C. et al. (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nature Medicine, 13(2), 150-155.
-
Kharolia, S. et al. (2022) Orexin receptor antagonists: a novel therapeutic approach for sleep disorders. Journal of Sleep Research, 31(4), e13567.